摩根士丹利：药明生物-在高浓度生物制品制造中突破极限

July 4, 2025 08:34 AM GMT WuXi Biologics Cayman Inc | Asia Pacific M Update Pushing the Envelope in High- Concentration Biologics Manufacturing Key Takeaways The highest-concentration biologic approved to date is Benlysta (belimumab): High-concentration is defined as levels exceeding 100mg/mL. Humira (adalimumab), for example, has a concentration level of 100mg/mL. Benlysta, GSK's novel treatment for lupus, is manufactured at 200mg/mL. WuXi's new platform is able to engineer concentrations of up to 230mg/mL ...